OnKure Therapeutics, Inc. Insider Transactions
OnKure Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
| Sell | 88 @ $2.62 | $231 | 3,506 | 09/22/2025 | 09/24/2025 | ||
| Sell | 303 @ $2.62 | $795 | 12,603 | 09/22/2025 | 09/24/2025 | ||
| Sell | 88 @ $2.38 | $210 | 3,594 | 06/23/2025 | 06/25/2025 | ||
| Sell | 303 @ $2.38 | $722 | 12,906 | 06/23/2025 | 06/25/2025 | ||
|
Cormorant Asset Management, LP
Other: Former 10% Owner |
Sell | 1,813,439 @ $1.85 | $3.36 M | 0 | 05/15/2025 | 05/19/2025 | |
|
ACORN BIOVENTURES, L.P.
10 percent owner |
Buy | 270,270 @ $1.85 | $500.00 K | 1,709,944 | 05/15/2025 | 05/19/2025 | |
|
ACORN BIOVENTURES, L.P.
10 percent owner |
Buy | 1,129,730 @ $1.85 | $2.09 M | 1,129,730 | 05/15/2025 | 05/19/2025 | |
|
Cormorant Asset Management, LP
10 percent owner |
Sell | 24,300 @ $1.99 | $48.24 K | 1,813,439 | 05/12/2025 | 05/14/2025 | |
| Sell | 516 @ $2.67 | $1.38 K | 3,682 | 04/07/2025 | 04/08/2025 | ||
| Sell | 1,844 @ $2.67 | $4.93 K | 13,209 | 04/07/2025 | 04/08/2025 | ||
| Sell | 358 @ $3.33 | $1.19 K | 4,198 | 04/04/2025 | 04/08/2025 | ||
| Sell | 1,278 @ $3.33 | $4.25 K | 15,053 | 04/04/2025 | 04/08/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
OnKure Therapeutics, Inc. FAQ's
The list of insiders at OnKure Therapeutics, Inc. includes Saccomano Nicholas A, Leverone Jason A., Cormorant Asset Management, LP, ACORN BIOVENTURES, L.P..
Insiders have sold a total of 1.84 M OnKure Therapeutics, Inc. shares in the last 12 months for a total of 3.42 M sold.
The following insiders have sold OnKure Therapeutics, Inc. shares in the last 12 months: Saccomano Nicholas A ($3.01 K), Leverone Jason A. ($10.70 K), Cormorant Asset Management, LP ($3.41 M),
Insiders have purchased a total of 1.40 M OnKure Therapeutics, Inc. shares in the last 12 months for a total of 2.59 M.
The following insiders have purchased OnKure Therapeutics, Inc. shares in the last 12 months: ACORN BIOVENTURES, L.P. ($2.59 M),